Table 2 Clinical central nervous system (CNS) manifestations in systemic lupus erythematosus patients included in the study
CNS manifestations | NPSLE (n = 36) | No NPSLE (n = 71) | Antiphospholipid antibody syndrome (n = 7) |
|---|---|---|---|
Acute confusional state | 2 (6%) | 1 (1.5%) | 0 (0%) |
Anxiety disorder | 1 (3%) | 5 (7%) | 0 (0%) |
Aseptic meningitis | 1 (3%) | 0 (0%) | 0 (0%) |
Cerebrovascular disease | 5 (14%) | 7 (10%) | 4 (57%) |
Cognitive dysfunction | 7 (19%) | 19 (27%) | 0 (0%) |
Demyelinating syndrome | 3 (8%) | 1 (1.5%) | 0 (0%) |
Headache | 8 (22%) | 28 (39%) | 3 (43%) |
Mood disorders | 7 (19%) | 10 (14%) | 1 (14%) |
Movement disorder | 2 (6%) | 0 (0%) | 0 (0%) |
Myastenia gravis | 0 (0%) | 2 (3%) | 0 (0%) |
Myelopathy | 2 (6%) | 0 (0%) | 0 (0%) |
Polyneuropathy | 0 (%) | 2 (3%) | 0 (0%) |
Mononeuropathy | 0 (0%) | 1 (1.5%) | 0 (0%) |
Neuropathy | 0 (0%) | 2 (3%) | 1 (14%) |
Psychosis | 2 (6%) | 1 (1.5%) | 0 (0%) |
Seizure disorders | 6 (17%) | 0 (0%) | 0 (0%) |